Token Offset

>started treating my Openclaw/Hermes like patients. >the bugs that kept coming back all had real medical names. take the one everyone calls "AI hallucination." medically it's confabulation. >now i scan for the organ that failed. gbrain handles memory. OpenClaw approvals handle actions. trajectory bundles handle self-check. >a healthier agent isn't a smarter brain. it's a more complete body. >a few weeks in, you stop blaming "the model." you find the broken organ and patch it.

JUST IN: Marc Andreessen reveals “AI vampires” are emerging in Silicon Valley — coders getting so little sleep because they stay up all night building with agents.

🦔Microsoft canceled its internal Claude Code licenses this week after token-based billing made the cost untenable, even for a company with effectively infinite cloud resources. Uber's CTO sent an internal memo warning the company burned through its entire 2026 AI budget in just four months. American AI software prices have jumped 20% to 37%, and GitHub (owned by Microsoft) is dropping flat-rate plans for usage-based billing across its products. My Take The AI subsidy era is ending in real time. The same company that put $13 billion into OpenAI and built the Azure infrastructure powering most of Anthropic's compute just looked at the bill from a competitor's coding tool and decided it was not worth paying. That is not a productivity failure on Anthropic's end. Token-based pricing is forcing every enterprise customer to confront the actual cost of running these models at scale, and the number turns out to be far higher than the flat-rate experiments suggested. This ties directly to my Gemini Flash post yesterday. Anthropic, OpenAI, and Google all raised effective prices in the last six months. Enterprises that built workflows assuming AI costs would keep falling are now watching annual budgets evaporate in months. Two outcomes look likely from here. Either enterprises scale back AI usage to fit budgets, which slows the revenue ramp the labs need to justify their valuations ahead of IPOs, or the labs cut prices and absorb the losses, which makes the unit economics worse at exactly the wrong moment. Both paths land in the same place, the numbers stop working, and somebody has to take the writedown. Hedgie🤗